Bayer wins lawsuit: EPA must review glyphosate again | Free press

Due to the herbicide glyphosate, Bayer has a large legal construction site in the US. Two important court decisions were made on Friday. One is for Bayer, the other is for the US Environmental Protection Agency.

San Francisco / Jackson County.

The U.S. Environmental Protection Agency has been ordered by an appeals court to re-examine the health risks of glyphosate.

A San Francisco court questioned the EPA’s assessment that the active ingredient in Bayer’s controversial Roundup weed control did not pose any particular risk to humans.

The topic is of great importance for the German Bayer group. He is facing numerous lawsuits in the US over alleged cancer risks associated with glyphosate. There was also good news for Dax on Friday: in the case in Oregon, she was another success in court. Bayer has now won the last four lawsuits in the United States, involving plaintiffs who blame glyphosate for cancer.

How dangerous is the pesticide?

The EPA recently reviewed the herbicide in 2020 and concluded that it does not pose a health risk when used correctly. She complained about this, among others environmental organization NRDC. “For years, the EPA has refused to do anything about the harmful effects of this pesticide on people and the environment,” the organization said on Friday. The court made it clear that things could not go on like this.

In its judgment, the relevant appellate court was particularly concerned about the way the EPA argued that glyphosate was not carcinogenic. The underlying analysis is ‘inadequate’ and not in line with the authority’s guidance. The EPA declined to comment on the criticism when asked to do so. A spokeswoman said the glyphosate decision would be reviewed.

Optimism at Bayer

In a statement, Bayer expressed confidence that the EPA did not find a cancer risk related to glyphosate even in a new review. The US government’s environmental protection agency has recently acted diligently and carried out a “rigorous” evaluation of scientific research over the past 40 years. Bayer took on the glyphosate lawsuits with the 2018 $ 60 billion acquisition of the seed giant Monsanto.

Many procedures in the US rely in particular on evaluation by the World Health Organization’s International Agency for Research on Cancer. In 2015, she classified the Monsanto weedkiller as “possibly carcinogenic” to humans. Bayer dismisses this, arguing with the approval of multiple regulators and studies to show that glyphosate is safe when used as directed.

The situation finally turned after Bayer lost the first three glyphosate lawsuits in the United States. On Friday, the Dax group won the fourth treatment in a row. The Jackson County, Oregon jury unanimously ruled that Roundup was not responsible for the plaintiff’s cancer. “We remain fully in favor of the protection of Roundup,” said Bayer. The group said it would “confidently” defend itself in all future legal conflicts on the subject. (dpa)

Leave a Comment